Angels Santé

Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.

Operator of a regenerative medicine company intended to develop breast regeneration alternatives by 3D bioprinting. The company develops a bioprosthesis for breast reconstruction, enabling women to regain their self-confidence through natural products and get long-lasting and aesthetic results after the surgery.

Vaxxel is a biotechnology company focused on developing innovative live-attenuated vaccines targeting critical respiratory diseases, specifically bronchiolitis and pneumonia caused by pneumoviruses. The company specializes in creating novel vaccine candidates aimed at treating infections associated with human metapneumovirus and the human respiratory virus. By leveraging its proprietary platform, Vaxxel aims to provide effective solutions for healthcare providers to combat these significant health challenges.

Mapatho developed an online medical directory and search platform designed to allow patients to find free medical and pathology experts.

Developer of therapeutic molecule intended to address unmet medical needs in neurological or inflammatory diseases. The company focuses on particular expertise in the fields of epilepsy and cognitive disorders and offers a portfolio of innovative lipid derivatives as drug candidates, enabling healthcare organizations to offer essential medicine to their patients.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

Omini is a company that specializes in the development of portable and multipurpose bio-sensing devices for blood tests, catering primarily to general practitioners. Established in 2019 and headquartered in Saint Mandé, France, Omini addresses a critical need in medical decision-making, as 70% of such decisions rely on clinical chemistry and assays like blood tests, which often require hours to days to yield results. The company’s innovative devices utilize multiplex electrochemical biosensor technology to simultaneously identify, analyze, and monitor multiple target biomarkers in real-time, allowing for quicker and more informed medical decisions. This technology not only facilitates decentralized testing and at-home monitoring for patients with chronic conditions but also aims to alleviate pressure on healthcare systems by providing affordable and immediate testing solutions.

Braintale develops and distributes accessible and effective diagnosis and prognosis tools for brain injured patients.

Hillo designs, develops, and operates artificial intelligence platform to transform diabetic patient's lives. The company develops tools to anticipate blood glucose level. Hillo was founded in 2016 and is based in Palaiseau, France.

Primaa is a French startup established in 2018, with its headquarters located in Orsay, France. Founded by three cousins, Fanny, Stéphane, and Marie Sockeel, the company specializes in creating software solutions aimed at assisting pathologists in the detection of cancer and other pathologies. Primaa's innovative approach involves an artificial intelligence-based tool that digitizes histological slides and compiles images into a database. This technology enables medical professionals to accurately identify tissue damage and perform a growing number of diagnoses while ensuring high reliability in their assessments. Through its advancements in medical diagnostic software, Primaa is enhancing the capabilities of pathologists in their vital work.

WeFight Inc. develops technology for health care sector. The company develops an application called Vik-Sein, which answers patients’ questions about breast cancer. Vik provides reminders to patients when to take treatment and smart tracking book to offer clinical trials that match their profile. The company was founded in 2017 and is based in Montpellier, France.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

C4Diagnostics is a company based in Marseille, France, that specializes in the development and commercialization of in vitro diagnostic (IVD) kits. Founded in 2017, the company focuses on creating technology that enables the detection, counting, and concentration of culturable microorganisms in clinical microbiology. Its innovative approach is designed to enhance the speed and sensitivity of diagnostic tests, particularly for urinary tract infections. By providing hospitals and laboratories with advanced tools for culture-based testing and specific fluorescence, C4Diagnostics aims to improve diagnostic accuracy and efficiency in medical settings.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, focuses on developing a non-invasive ultrasonic medical device aimed at treating heart valve diseases, particularly calcified aortic stenosis. The device utilizes real-time image guidance and ultrasound technology to perform treatments without causing thermal injury, allowing clinicians to address conditions swiftly and improve the chances of successful outcomes. With a management team experienced in innovation, Cardiawave has raised over €14 million since its inception to advance its product development and conduct preclinical studies, with plans for first-in-man trials initially anticipated in 2019. The company is recognized for its contributions to the field of cardiac care, having won accolades such as the 2017 Prize at the Worldwide Innovation Contest.

PREMEDIT SAS is a French company that specializes in developing application software branded as Running Care, aimed at helping runners predict, prevent, and manage injuries and pain. Utilizing artificial intelligence, the software monitors runners' health and serves as a class I medical device for diagnosing and rehabilitating running-related injuries, compliant with relevant medical regulations. In addition to its core functionalities, Running Care offers integration with other running applications, affiliate marketing for sports and healthcare products, and provides a platform for content aimed at non-healthcare professionals. The company, founded in 2016 and headquartered in Loos, France, also focuses on sports medicine data analysis and promoting awareness of health issues related to sports.

Hillo designs, develops, and operates artificial intelligence platform to transform diabetic patient's lives. The company develops tools to anticipate blood glucose level. Hillo was founded in 2016 and is based in Palaiseau, France.

Auxivia is a Paris-based company founded in 2015 that focuses on developing innovative solutions for healthy aging. The company designs a connected glass that integrates with an online platform to monitor individual water intake, providing alerts to prevent dehydration. Additionally, Auxivia offers intelligent services aimed at enhancing the quality of caregiving for elderly individuals experiencing a loss of autonomy. Through its products, Auxivia seeks to promote better health management and support for aging populations.

Cypheme is an artificial intelligence capable of detecting counterfeit products by analyzing the product's packaging with a neural network, using only a cellphone camera.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, focuses on developing a non-invasive ultrasonic medical device aimed at treating heart valve diseases, particularly calcified aortic stenosis. The device utilizes real-time image guidance and ultrasound technology to perform treatments without causing thermal injury, allowing clinicians to address conditions swiftly and improve the chances of successful outcomes. With a management team experienced in innovation, Cardiawave has raised over €14 million since its inception to advance its product development and conduct preclinical studies, with plans for first-in-man trials initially anticipated in 2019. The company is recognized for its contributions to the field of cardiac care, having won accolades such as the 2017 Prize at the Worldwide Innovation Contest.

BibeliB is a brand of smart and trendy travel accessories. They created the first smart suit case. This suitcase bag is equipped with e an integrated traceability and insurance system. Thanks to our My BibeliB Paris app your suitcase cover is now connected to geolocate your suitcase and activate it more easily.

Medicapp Connect S.A.S. is a company based in Paris, France, established in 2011, that specializes in developing healthcare software solutions. The company designs and develops applications, including the Medicapp EHR mobile application, which assists healthcare professionals in managing health records, documents, photos, and notes. Medicapp Connect focuses on creating software that enables healthcare providers to efficiently create, organize, and communicate patient records, thereby simplifying the record-keeping process. The company's offerings are particularly beneficial for physiotherapists and other healthcare professionals, facilitating better management of patient data.